Lifevantage (LFVN)
(Delayed Data from NSDQ)
$10.78 USD
+0.48 (4.66%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $10.81 +0.03 (0.28%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Lifevantage Corporation falls in the month of June .
All items in Millions except EPS data.
6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | |
---|---|---|---|---|---|
Sales | 200 | 213 | 206 | 220 | 233 |
Cost Of Goods | 41 | 43 | 38 | 38 | 38 |
Gross Profit | 159 | 170 | 168 | 182 | 195 |
Selling & Adminstrative & Depr. & Amort Expenses | 154 | 166 | 161 | 164 | 179 |
Income After Depreciation & Amortization | 4 | 4 | 8 | 18 | 15 |
Non-Operating Income | 0 | 0 | -3 | 0 | -1 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 4 | 4 | 5 | 17 | 15 |
Income Taxes | 1 | 1 | 2 | 4 | 3 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 3 | 3 | 3 | 13 | 12 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 3 | 3 | 3 | 13 | 12 |
Depreciation Footnote | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 8 | 8 | 13 | 23 | 21 |
Depreciation & Amortization (Cash Flow) | 4 | 4 | 5 | 6 | 5 |
Income After Depreciation & Amortization | 4 | 4 | 8 | 18 | 15 |
Earnings Per Share Data | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
---|---|---|---|---|---|
Average Shares | 12.99 | 12.57 | 13.07 | 14.27 | 14.60 |
Diluted EPS Before Non-Recurring Items | 0.59 | 0.24 | 0.41 | 1.00 | 0.86 |
Diluted Net EPS (GAAP) | 0.23 | 0.20 | 0.24 | 0.90 | 0.79 |
Fiscal Year end for Lifevantage Corporation falls in the month of June .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 48.93 | 48.25 | 51.62 | 51.36 | 54.22 |
Cost Of Goods | 10.02 | 10.17 | 11.07 | 10.18 | 11.07 |
Gross Profit | 38.91 | 38.07 | 40.56 | 41.18 | 43.15 |
SG&A, R&D, and Dept/Amort Expenses | 36.00 | 36.14 | 41.82 | 40.44 | 40.55 |
Income After SG&A, R&D, and Dept/Amort Expenses | 2.91 | 1.93 | -1.26 | 0.74 | 2.60 |
Non-Operating Income | -0.28 | -0.01 | 0.15 | 0.08 | -0.15 |
Interest Expense | -0.43 | 0.00 | 0.00 | 0.00 | -0.11 |
Pretax Income | 2.71 | 1.92 | -1.11 | 0.83 | 2.56 |
Income Taxes | 1.41 | 0.26 | -0.46 | 0.20 | 0.59 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 1.31 | 1.66 | -0.66 | 0.63 | 1.97 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 1.31 | 1.66 | -0.66 | 0.63 | 1.97 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 12.87 | 12.99 | 12.61 | 13.11 | 12.98 |
Diluted EPS Before Non-Recurring Items | 0.14 | 0.21 | 0.10 | 0.13 | 0.17 |
Diluted Net EPS (GAAP) | 0.10 | 0.13 | -0.05 | 0.05 | 0.15 |